Suppr超能文献

胃癌患者的术前免疫疗法——特别提及用单克隆抗体分析T淋巴细胞亚群及口服OK-432(匹多莫德)白介素-2

[Preoperative immunotherapy in patients with gastric cancer--with special reference to analysis with monoclonal antibodies of T-lymphocyte subsets and interleukin-2 oral administration of OK-432 (Picibanil)].

作者信息

Izumi M

机构信息

Second Department of Surgery, Gunma University School of Medicine, Maebashi, Japan.

出版信息

Nihon Geka Gakkai Zasshi. 1993 Jan;94(1):27-32.

PMID:8437550
Abstract

The effects of oral administration of OK-432 on immune reactivities of gut associated lymphoid tissue (GALT) were studied in patients with gastric cancer. The lymphocytes of peripheral blood, regional lymph nodes and spleen in patients with gastric cancer were measured by using different monoclonal antibodies and flow cytometry. OKT3, OKT4, OKT8, OKM1, OKT4+2H4+, OKT4+2H4-, OKT8+Leu15+ and OKT8+1Leu5- were used as monoclonal antibodies. The NK activity, Interleukin-2 production and Interleukin-2 receptor were also measured. After oral administration of OK432, 1) little change was found in peripheral blood and spleen, 2) the percentages of OKT3, OKT4, OKT4+2H4- and the ratio of OKT4/OKT8 were increased in proximal regional lymph nodes, and 3) the percentages of OKT8 and OKT8+Leu15- in regional lymph nodes were not changed. These results suggest that the helper T cell activity and the antitumor immunity of regional lymph nodes were elevated by oral administration of OK-432.

摘要

研究了口服溶链菌制剂(OK-432)对胃癌患者肠道相关淋巴组织(GALT)免疫反应性的影响。采用不同的单克隆抗体和流式细胞术检测胃癌患者外周血、区域淋巴结和脾脏的淋巴细胞。使用OKT3、OKT4、OKT8、OKM1、OKT4+2H4+、OKT4+2H4-、OKT8+Leu15+和OKT8+1Leu5-作为单克隆抗体。还检测了自然杀伤(NK)活性、白细胞介素-2产生和白细胞介素-2受体。口服OK432后,1)外周血和脾脏未见明显变化,2)近端区域淋巴结中OKT3、OKT4、OKT4+2H4-的百分比以及OKT4/OKT8比值升高,3)区域淋巴结中OKT8和OKT8+Leu15-的百分比未改变。这些结果表明,口服OK-432可提高区域淋巴结的辅助性T细胞活性和抗肿瘤免疫力。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验